全文获取类型
收费全文 | 2531940篇 |
免费 | 176720篇 |
国内免费 | 3382篇 |
专业分类
耳鼻咽喉 | 33517篇 |
儿科学 | 83180篇 |
妇产科学 | 66110篇 |
基础医学 | 366323篇 |
口腔科学 | 65474篇 |
临床医学 | 224158篇 |
内科学 | 491007篇 |
皮肤病学 | 52680篇 |
神经病学 | 201440篇 |
特种医学 | 97177篇 |
外国民族医学 | 489篇 |
外科学 | 385898篇 |
综合类 | 50440篇 |
现状与发展 | 12篇 |
一般理论 | 850篇 |
预防医学 | 200069篇 |
眼科学 | 57548篇 |
药学 | 185202篇 |
12篇 | |
中国医学 | 5247篇 |
肿瘤学 | 145209篇 |
出版年
2021年 | 19628篇 |
2019年 | 20033篇 |
2018年 | 47840篇 |
2017年 | 36889篇 |
2016年 | 42088篇 |
2015年 | 26960篇 |
2014年 | 37470篇 |
2013年 | 55452篇 |
2012年 | 82170篇 |
2011年 | 99895篇 |
2010年 | 64612篇 |
2009年 | 55951篇 |
2008年 | 93984篇 |
2007年 | 101761篇 |
2006年 | 81530篇 |
2005年 | 80727篇 |
2004年 | 78864篇 |
2003年 | 77525篇 |
2002年 | 73167篇 |
2001年 | 109358篇 |
2000年 | 112394篇 |
1999年 | 93937篇 |
1998年 | 27364篇 |
1997年 | 24076篇 |
1996年 | 24277篇 |
1995年 | 22956篇 |
1994年 | 21145篇 |
1993年 | 19907篇 |
1992年 | 72257篇 |
1991年 | 70373篇 |
1990年 | 68682篇 |
1989年 | 65911篇 |
1988年 | 60493篇 |
1987年 | 59321篇 |
1986年 | 55391篇 |
1985年 | 53190篇 |
1984年 | 39456篇 |
1983年 | 33565篇 |
1982年 | 19990篇 |
1979年 | 36029篇 |
1978年 | 25766篇 |
1977年 | 21291篇 |
1976年 | 20438篇 |
1975年 | 21856篇 |
1974年 | 26227篇 |
1973年 | 24869篇 |
1972年 | 23274篇 |
1971年 | 22087篇 |
1970年 | 20323篇 |
1969年 | 19381篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
K A Burkman R W Gaines S R Kashani R D Smith 《Archives of physical medicine and rehabilitation》1988,69(2):132-134
Herpes zoster probably occurs more often than generally thought. Since it produces a radicular distribution of pain, it should be included in the differential diagnosis of radiculopathy. A case is presented in which evaluating the radicular low back pain before the characteristic rash appears was misleading. Careful history-taking concerning the exact nature of the pain and sensory changes is needed to differentiate between zoster and radiculopathy, if no rash is evident. 相似文献
995.
996.
997.
Eledoisin has been tried as a possible treatment for dry eye based on the hypothesis that it pharmacologically stimulates tear secretion when topically applied to the eye. To determine if topically applied eledoisin pharmacologically stimulates orbital lacrimal secretion, the orbital lacrimal gland excretory duct of normal rabbits was cannulated, and eledoisin was applied topically with and without prior administration of proparacaine. To determine if topically applied eledoisin stimulated accessory lacrimal gland secretion, isotonic buffer with and without eledoisin was tested in a rabbit model with only accessory lacrimal tissue remaining after the administration of proparacaine. Topically applied eledoisin did not pharmacologically stimulate lacrimal secretion but rather increased lacrimal gland secretion only in non-anesthetized eyes through a sensory reflex mechanism that is blocked by proparacaine. 相似文献
998.
R W Hertle A B Leahey S Bloom D B Schaffer S Bartlett 《Ophthalmic plastic and reconstructive surgery》1990,6(4):278-282
Chorioretinal folds have been reported as a result of many intraocular and extraocular inflammatory processes or tumors. Visual loss is usually secondary to a combination of the underlying process and chorioretinal folds involving the macula. We report a patient who developed decreased vision, metamorphopsia, chorioretinal folds, and a lamellar macular hole secondary to global compression by a bone fragment. The chorioretinal folds regressed and his vision stabilized following surgical decompression. Chorioretinal folds and lamellar macular hold formation are previously unrecognized complications of reconstructive craniofacial surgery. 相似文献
999.
J. M. Falletta B. Cushing S. Lauer B. Bell D. H. Mahoney R. Castleberry R. A. Krance 《Investigational new drugs》1990,8(2):167-170
Summary We conducted a phase I clinical study of aziridinylbenzoquinone (Diaziquone, AZQ) given as a 4 hour infusion weekly × 4. Forty-five children with recurrent acute leukemia and 33 children with various advanced solid tumors participated. Severe myelosuppression was the dose limiting toxic effect, occurring in all patients at the upper dose levels. Gastrointestinal and hepatic toxicities were infrequent and not severe. No allergic reactions occurred. Objective tumor regression was noted in 3 of 25 patients with a CNS tumor and in 6 of 45 patients with acute leukemia. For phase II trials the recommended dosage of Diaziquone given by this schedule is 18 mg/M2×4 for patients with a solid tumor, and is 30 mg/M2/week × 4 for children with acute leukemia. 相似文献
1000.
B. A. Johnson Donald R. Jasinski Gantt P. Galloway Henry Kranzler Robert Weinreib Raymond F. Anton Barbara J. Mason Michael J. Bohn Helen M. Pettinati Richard Rawson Christopher Clyde 《Psychopharmacology》1996,128(2):206-215
Four hundred and twenty-three alcohol dependent subjects were enrolled into a 12-week randomized, double-blind, placebo-controlled
study to determine the safety and efficacy of the 5-HT2 receptor antagonist, ritanserin (2.5 mg/day or 5 mg/day), in reducing alcohol intake and craving. All subjects received 1
week of single-blind placebo prior to randomization into the 11-week double-blind phase. Additionally, all subjects received
weekly individual sessions of manual-guided cognitive-behavioral therapy. Comparing the single-blind period with endpoint,
there was approximately a 23% reduction in drinks/day; 34% fall in the total number of drinking days/week; 22% decrease in
drinks/drinking day; and a 37% diminution in alcohol craving for all treatment groups. All treatment groups experienced a
beneficial clinical outcome as assessed by the Clinical Global Impression Scale. There was, however, no significant difference
between treatment groups on any of these measures of alcohol drinking, craving, or clinical outcome. Subjects were of relatively
high social functioning at baseline, and this did not change significantly during treatment. Treatment groups did not differ
significantly on either medication compliance or reported adverse events. Ritanserin treatment was associated with a dose-related
prolongation of subjects’ QTc interval recording on the electrocardiogram. These results suggest that alcohol dependent subjects
can show marked clinical improvement within a structured alcohol treatment program. These findings do not support an important
role for ritanserin in the treatment of alcohol dependence.
Received: 30 April 1996/Final version: 3 July 1996 相似文献